trending Market Intelligence /marketintelligence/en/news-insights/trending/gvkf3ojarmsjopda66qx-a2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Lawsuit against Intercept Pharmaceutical directors dismissed by US court

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Lawsuit against Intercept Pharmaceutical directors dismissed by US court

Intercept Pharmaceuticals Inc. said a U.S. court granted a motion to dismiss a shareholder lawsuit which alleged that company directors breached their fiduciary duty.

The Supreme Court of the State of New York, County of New York dismissed the suit, Solak v. Fundaro, et al., which was filed August 2017, purportedly on behalf of the company.

The suit alleged that company directors violated the company's nonexecutive director compensation practices.

The New York-based biopharmaceutical company said the ruling is subject to appeal.